Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
LPAR1 Biologics Sequence Review Report 2026: Lysophosphatidic acid receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LPAR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LCOR Biologics Sequence Review Report 2026: Ligand-dependent corepressor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of LCOR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
L1CAM Biologics Sequence Review Report 2026: Neural cell adhesion molecule L1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of L1CAM sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KITLG Biologics Sequence Review Report 2026: Kit ligand Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of KITLG sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
JAML Biologics Sequence Review Report 2026: Junctional adhesion molecule-like Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of JAML sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
JAM3 Biologics Sequence Review Report 2026: Junctional adhesion molecule C Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of JAM3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
JAM2 Biologics Sequence Review Report 2026: Junctional adhesion molecule B Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of JAM2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGB1BP2 Biologics Sequence Review Report 2026: Integrin beta-1-binding protein 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ITGB1BP2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGA11 Biologics Sequence Review Report 2026: Integrin alpha-11 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ITGA11 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
INSRR Biologics Sequence Review Report 2026: Insulin receptor-related protein Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of INSRR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IGFL4 Biologics Sequence Review Report 2026: Insulin growth factor-like family member 4 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of IGFL4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IGFL3 Biologics Sequence Review Report 2026: Insulin growth factor-like family member 3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of IGFL3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
215
216
217
218
219
>>
2260
>